Leaflet OCTAPLASLG 45-70mg / ml solution for infusion

Product code:
W65357001
Indicated for:
plasma factor replacement; coagulopathy
Route of administration:
infusion
ATC
B05AA — Blood and blood forming organs | Blood and related products | Blood substitutes and plasma protein fractions

Human plasma proteins of blood groups A, B, AB, 0 are used for various medical purposes, including plasma replacement therapies.
They contain clotting factors, immunoglobulins, and other essential proteins necessary for normal body function.

They are particularly used in cases of massive blood loss, coagulation disorders, or immune deficiencies.
They may also be administered in treatments for severe burns or during major surgical procedures.

Side effects may include allergic reactions, fever, or, in rare cases, infections transmitted through plasma.
It is essential to perform compatibility tests before administration and monitor the patient during treatment.

General data about OCTAPLASLG 45-70mg / ml

Substance:
human plasma proteins of blood group A, B, AB, 0
Product code:
W65357001
Concentration:
45-70mg / ml
Pharmaceutical form:
solution for infusion
Product type:
Generic medicine
Prescription status:
S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.

Marketing authorisation

Manufacturer:
OCTAPHARMA AB - SUEDIA
Holder:
OCTAPHARMA (IP) SPRL - BELGIA
Number:
13602/2020/01
Shelf life:
4 years